Catalyst Wire Dossier Catalyst Wire Dossier

NVR 3-778

· Novira Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NVR 3-778, covering 2017-10-18 to 2017-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients [Phase 1]

See pricing